Relationship of Metabolic Syndrome With Incident Aortic Valve Calcium and Aortic Valve Calcium Progression The Multi-Ethnic Study of Atherosclerosis (MESA)

Ronit Katz; Matthew J. Budoff; Junichiro Takasu; David M. Shavelle; Alain Bertoni; Roger S. Blumenthal; Pamela Ouyang; Nathan D. Wong; Kevin D. O'Brien

doi:10.2337/db08-1515

Relationship of Metabolic Syndrome With Incident Aortic Valve Calcium and Aortic Valve Calcium Progression

The Multi-Ethnic Study of Atherosclerosis (MESA)*

¹University of Washington, Seattle, Washington;
²Harbor-UCLA Medical Center, Torrance, California;
³Wake Forest University, Winston-Salem, North Carolina;
⁴Johns Hopkins Medical Institutions, Baltimore, Maryland; and
⁵University of California–Irvine, Irvine, California.

Corresponding author: Ronit Katz, rkatz{at}u.washington.edu.

Abstract

OBJECTIVE Metabolic syndrome (MetS) has been associated with increased prevalence of aortic valve calcium (AVC) and with increased progression of aortic stenosis. The purpose of this study was to determine whether MetS is associated with increased risks for the development of new (“incident”) AVC or for progression of established AVC as assessed by CT.

RESEARCH DESIGN AND METHODS The relationships of MetS or its components as well as of diabetes to risks for incident AVC or AVC progression were studied among participants with CT scans performed at baseline and at either year 2 or year 3 examinations in the Multi-Ethnic Study of Atherosclerosis (MESA).

RESULTS Of 5,723 MESA participants meeting criteria for inclusion, 1,674 had MetS by Adult Treatment Panel III criteria, whereas 761 had diabetes. Among the 5,123 participants without baseline AVC, risks for incident AVC, adjusted for time between scans, age, sex, race/ethnicity, LDL cholesterol, lipid-lowering medications, and smoking, were increased significantly for MetS (odds ratio [OR] 1.67 [95% CI 1.21–2.31]) or diabetes (2.06 [1.39–3.06]). In addition, there was an increase in incident AVC risk with increasing number of MetS components. Similar results were found using the International Diabetes Federation MetS criteria. Among the 600 participants (10.5%) with baseline AVC, neither MetS nor diabetes was associated with AVC progression.

CONCLUSIONS In the MESA cohort, MetS was associated with a significant increase in incident (“new”) AVC, raising the possibility that MetS may be a potential therapeutic target to prevent AVC development.

Footnotes

*A full list of participating MESA investigators and institutions may be found at http://www.mesa-nhlbi.org.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
- Received October 31, 2008.
- Accepted January 4, 2009.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.